New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Did Virat Kohli Deactivate His Instagram Account? Fans & Followers Left In Speculation
Bhandup Murder Case: Police Informer ‘Fotu’ Named As Key Conspirator; Allegations Of Political Pressure On Police
Bombay HC Allows Son’s Appeal, Declares Man Missing Since 2003 As Presumed Dead; Sets Aside Trial Court Order
Mumbai Civic Watch: Race Heats Up For Next BMC Commissioner As Bhushan Gagrani Set To Retire In March 2026
